Health Ministry Invites Application For Deputy Director at CDSCO's CDTL Mumbai, Salary Up to Rs 2.09 L Farhat Nasim16 Feb 2025 3:00 PM ISTNew Delhi: The Ministry of Health and Family Welfare has invited applications for the post of Deputy Director at the Central Drugs Testing...
GSK Pharma's Q3 Profit Jumps 35% on Strong Demand for Augmentin, Respiratory Drugs Farhat Nasim16 Feb 2025 11:45 AM ISTBengaluru: India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its...
Surprise Inspection of Pharma Firms in Baddi Amid Counterfeit Drug Concerns Farhat Nasim16 Feb 2025 10:30 AM ISTJaipur: To ensure the quality of medicines supplied under the Chief Minister's Free Medicine Scheme, surprise inspection of pharma firms in Baddi was...
Moderna's Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales Slump Farhat Nasim16 Feb 2025 9:30 AM ISTBengaluru: Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid...
West Pharma's 2025 Forecast Misses Estimates as Inventory Reductions Continue Farhat Nasim16 Feb 2025 9:30 AM ISTBengaluru: West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as...
Retinal examination be done at each visit: CDSCO Panel tells Alkem Lab on Semaglutide Injection Phase III CT study Dr. Divya Colin15 Feb 2025 6:00 PM ISTNew Delhi: Considering the bioequivalence study report of Semaglutide Injection 2 mg presented by the drug major Alkem Laboratories, the Subject...
Zydus' Ambernath API Plant Clears USFDA Inspection with Zero Observations Farhat Nasim15 Feb 2025 4:42 PM ISTAhmedabad: Zydus Lifesciences Limited has announced the successful completion of a USFDA surveillance inspection at its Active Pharmaceutical...
US Market Pressure Weighs on Glenmark's Q3 Earnings, Profit Below Estimates Farhat Nasim15 Feb 2025 3:35 PM ISTGlenmark reported a consolidated net profit of 3.48 billion rupees (USD 40.15 million) for the quarter ended December 31.
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case Farhat Nasim15 Feb 2025 3:25 PM ISTBengaluru: Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a rare...
USFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy Farhat Nasim15 Feb 2025 10:45 AM ISTEvrysdi is the only non-invasive disease-modifying treatment for SMA.
Shilpa Medicare Gets CDSCO Panel Nod for Novel NAFLD Drug, Advances to Marketing Approval Stage Farhat Nasim14 Feb 2025 2:04 PM ISTRaichur: Shilpa Medicare Limited, recently announced that its Investigational New Drug (IND), Nor-Ursodeoxycholic Acid Tablets (500 mg), has received...
Natco Pharma Q3 Profit Falls 38% to Rs132 Cr Amid Formulation Export Slump Farhat Nasim14 Feb 2025 1:30 PM ISTNatco reported consolidated revenue of Rs 474.8 crore for the quarter, down from Rs 758.6 crore a year ago.
